Research Article
A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria
Table 1
Clinical characteristics and laboratory findings of TURDEP-II study population
.
| Parameter | Women ( = 13,676) | Men ( = 7,809) | value |
| Age (year) | 43 (15) | 44.7 (15.6) | <0.000001 | BMI (kg/m2) | 28.6 (5.7) | 27.2 (4.3) | <0.000001 | Waist (cm) | 91.3 (14.5) | 96.4 (12.8) | <0.000001 | Hip (cm) | 108.6 (13.2) | 105.1 (10.3) | <0.000001 | SBP (mmHg) | 118 (27) | 120 (22) | 0.000008 | DBP (mmHg) | 74 (13) | 75 (12) | <0.000001 | HR (beat/min) | 79.5 (8.7) | 78.3 (9.2) | <0.000001 | hs-CRP (mg/L) nmol/L] | 1.85 (3.09) 17.6 (29.4) | 1.47 (2.33) 14.0 (22.2) | <0.000001 | FPG (mmol/L) | 5.5 (1.03) | 5.48 (1.18) | 0.000449 | HbA1c (mmol/mol) %] | 38 (7) 5.6 (0.6)] | 37 (8) 5.5 (0.7)] | 0.003493 | 1-hPG (mmol/L) | 8.9 (2.5) | 8.76 (2.52) | 0.000013 | 2-hPG (mmol/L) | 7.2 (2.1) | 6.34 (2.04) | <0.000001 | Creatinine (μmol/L) | 64.0 (11.0) | 82.0 (14.4) | <0.000001 | Triglycerides (mmol/L) | 1.4 (0.8) | 1.67 (1.15) | <0.000001 | HDL-cholesterol (mmol/L) | 1.3 (0.3) | 1.09 (0.27) | <0.000001 | Non-HDL-cholesterol (mmol/L) | 3.5 (1.0) | 3.69 (1.01) | <0.000001 | Fasting insulin (pmol/L) | 56.4 (49.6) | 56.9 (60.5) | 0.570725 | HOMA-IR | 1.9 (2.9) | 2.0 (3.1) | 0.258439 | eGFR (mL/min per 1.73 m2) mL/s per 1.73 m2] | 101.0 (17.4) 0.14 (0.04)] | 98.8 (16.9) 0.13 (0.04)] | <0.000001 |
|
|
mean (SD); median (IQR); CKD-EPI equation. 1-hPG, oral glucose tolerance test 1st hour plasma glucose; 2-hPG, oral glucose tolerance test 2nd hour plasma glucose; BMI, body mass index; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL-cholesterol, high density lipoprotein cholesterol; HOMA-IR, homeostasis model of assessment; HR, heart rate; hs-CRP, high sensitive C-reactive protein; IQR, interquartile range; SBP systolic blood pressure.
|